Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 1, 2016updated 02 Dec 2021 12:16pm

Recordati takes over Italian pharmaceutical company Italchimici for €130m

International pharmaceutical group Recordati has acquired 100% stake in Italian pharmaceutical company Italchimici for €130m.

By Lopamudra Roy

International pharmaceutical group Recordati has acquired 100% stake in Italian pharmaceutical company Italchimici for €130m.

Recordati has made the acquisition from Progressio SGR, manager of the fund Progressio Investimenti II, IDeA Capital Funds SGR, manager of the fund Fondo IDeA Efficienza Energetica e Sviluppo Sostenibile, and from managers of Italchimici itself.

Recordati chairman and chief executive officer Giovanni Recordati said: “The acquisition of Italchimici represents an excellent opportunity to accelerate growth within the group, and in particular the Italian market, with an interesting portfolio of well-known products that have significant market shares.

“We are developing a growing presence within the area of gastroenterology and the consolidated Italchimici brands, much appreciated by the medical community, represent a valid complement to our current portfolio.”

“The acquisition of Italchimici represents an excellent opportunity to accelerate growth within the group, and in particular the Italian market.”

The €130m transaction value will be funded by Recordati from existing liquidity.

Progressio chief executive officer Filippo Gaggini said: “Thanks to extraordinary managers such as Riccardo Zagaria (CEO), Emanuele Loiacono (Commercial Director), Barbara Mazza (Strategic Marketing Director) and Riccardo Baraldi (CFO), we have been able to complete a very interesting transaction in the pharmaceutical sector.

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

“Once again we have shown how important it is in the management of a fund to be able to identify, with the support of quality managers, companies with solid fundamentals and development potential.”

Headquartered in Milan, Italchimici enjoyed revenues of €46m last year.

The Italian pharmaceutical company provides therapeutical solutions, which comprise pharmaceutical products and food supplements, as well as medical devices primarily for gastroenterological and respiratory problems.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU